HALO Competitors

NGS

Halozyme Therapeutics, Inc.

Healthcare•Biotechnology

Peers:MNKD•LLY•BAX•PFE•SNY

$111.08

+$0.66 (+0.60%)

1Y Target

$101.30

-8.8%

Prev Close

$110.42

Open

$110.19

Volume

1.66M

Market Cap

$12.53B

52 Week Range

$61.23

$116.85

See all ETFs with HALO

Prev Close:$110.42

Open:$110.19

Volume:1.66M

Market Cap:$12.53B

52 Week Range

$61.23

$116.85

See all ETFs with HALO

63

MarketXLS Rank ®

60

Value ®

66

Technical

65

Quality

How is this score calculated?

HALO Competitors

Halozyme Therapeutics, Inc.

$111.08

+$0.66(+0.60%)

63

Overall

60

Value

66

Tech

65

Quality

How is this score calculated?

Market Cap

$12.53B

Volume

1.66M

52W Range

$61.23 - $116.85

Target Price

$101.30

HALO competitors: MNKD, LLY, BAX, PFE, SNY. Halozyme Therapeutics, Inc. is compared with its Healthcare peers on market cap, P/E ratio, dividend yield and performance.

HALO Competitors Compared

Company	Price	Market cap	EPS est. (current yr)	Dividend yield	MarketXLS Rank
MNKD MannKind Corporation	$3.13	$1.06B	$-0.20	-	24
LLY Eli Lilly and Company	$1182.62	$1.11T	$36.19	0.57%	60
BAX Baxter International Inc.	$24.74	$12.59B	$2.04	0.16%	61
PFE Pfizer Inc.	$28.45	$161.19B	$2.96	6.05%	70
SNY Sanofi	$39.81	$97.72B	$5.00	6.08%	57

Get Halozyme Therapeutics, Inc. Data in Excel

Stream real-time stock prices and financials directly into your spreadsheets with MarketXLS.

BUY NOW

	A	B	C	D
1	Symbol	Price	Change	Volume
2	HALO	$111.08	+0.60%	1.66M
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	HALO	$111.08	+0.6%	1.66M
3
4
5
6

Get Halozyme Therapeutics, Inc. Data in Excel

Stream real-time data directly to your spreadsheets

BUY NOW